Gut microbiome-wide association study of depressive symptoms

Summary

This gut microbiome-wide association study identified thirteen microbial genera and one family significantly associated with depressive symptoms, validated across two independent Dutch population cohorts totalling 2,593 participants. The identified taxa are known to synthesise key neurotransmitters implicated in depression (glutamate, butyrate, serotonin, GABA), suggesting that microbiome composition may mechanistically contribute to depressive pathogenesis. The findings support the emerging hypothesis that the gut microbiota plays a role in mood disorders, though causal inference and the directionality of the microbiome-depression relationship remain to be established.

UK applicability

These findings may be applicable to UK populations, given the similar genetic background and environmental exposures of Dutch and British cohorts. However, dietary patterns and antibiotic use—key microbiome determinants—differ between populations, so UK replication studies would help establish generalisability and inform microbiome-targeted interventions for depression in British healthcare settings.

Key measures

Fecal microbiome diversity and composition (via 16S rRNA gene sequencing or metagenomic profiling, inferred); depressive symptom severity (validated depression scales, inferred); associations between specific microbial taxa abundance and depression scores

Outcomes reported

The study identified thirteen microbial taxa associated with depressive symptoms in two independent population cohorts (Rotterdam Study, n=1,054; Amsterdam HELIUS, n=1,539) and characterised their putative roles in neurotransmitter synthesis. These bacteria are implicated in the production of glutamate, butyrate, serotonin and gamma-aminobutyric acid (GABA), suggesting mechanistic links between microbiome composition and depressive symptomatology.

Topic tags